Profile - To The Moon

ETCH

Posts · 27Posts · 27
Following · 0Following · 0
Followers · 0Followers · 0

- ETCHETCH
  ·2021-09-10
  Time is running out for market share
  Why Novavax Stock Slipped Thursday
  (Update: Sept 10, 2021 at 04:14 a.m. ET) Authorization of the company's COVID-19 vaccine in India a
  Why Novavax Stock Slipped Thursday
  3.29K 1
  7
  Share
  Report
- ETCHETCH
  ·2021-08-24
  Great
  Sorry, this post has been deleted
  2.25K Comment
  3
  Share
  Report
- ETCHETCH
  ·2021-08-11
  X, CLF, NUE, AA.. all the materials stock ready toboom on this deal
  Sorry, this post has been deleted
  2.83K 3
  6
  Share
  Report
- ETCHETCH
  ·2021-08-09
  Ok
  Sorry, this post has been deleted
  2.65K Comment
  2
  Share
  Report
- ETCHETCH
  ·2021-08-06
  Submitted EUA in India, Indonesia and PhilippinesThose are the markets where vaccine are needed
  Sorry, this post has been deleted
  3.63K 1
  3
  Share
  Report
- ETCHETCH
  ·2021-08-04
  Pfizer slow and steady NVAX roller coaster rideChoose your poison
  Sorry, this post has been deleted
  2.86K Comment
  8
  Share
  Report
- ETCHETCH
  ·2021-08-01
  ok well
  Sorry, this post has been deleted
  3.21K Comment
  5
  Share
  Report
- ETCHETCH
  ·2021-07-30
  Inflation rate keep climbing.. correction soon..
  Sorry, this post has been deleted
  2.79K Comment
  3
  Share
  Report
- ETCHETCH
  ·2021-07-29
  Buy index and sleep well at night
  Sorry, this post has been deleted
  3.78K 2
  5
  Share
  Report
- ETCHETCH
  ·2021-07-26
  Nice
  Lockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate
  Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same
  Lockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate
  2.53K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3576835084140349","uuid":"3576835084140349","gmtCreate":1613741215736,"gmtModify":1704447500967,"name":"ETCH","pinyin":"etch","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":14,"headSize":17,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":883490547,"gmtCreate":1631261575289,"gmtModify":1676530512000,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Time is running out for market share","listText":"Time is running out for market share","text":"Time is running out for market share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/883490547","repostId":"1158877090","repostType":4,"repost":{"id":"1158877090","kind":"news","pubTimestamp":1631259068,"share":"https://ttm.financial/m/news/1158877090?lang=en_US&edition=fundamental","pubTime":"2021-09-10 15:31","market":"us","language":"en","title":"Why Novavax Stock Slipped Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158877090","media":"Motley Fool","summary":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India a","content":"<p><i><b>(Update: Sept 10, 2021 at 04:14 a.m. ET)</b></i></p>\n<blockquote>\n <b>Authorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>A report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.</li>\n <li>EUA for the vaccine in India was originally expected in October but will now be pushed back.</li>\n <li>The delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.</li>\n</ul>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by&nbsp;<i>The Economic Times</i>&nbsp;that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).</p>\n<p><b>So what</b></p>\n<p>SII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according to<i>The Economic Times</i>&nbsp;article.</p>\n<p>The problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.</p>\n<p>This delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.</p>\n<p><b>Now what</b></p>\n<p>Novavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.</p>\n<p>Novavax fell over 2% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/d6cab4a5dd8795f7fda9bc597e6d9d98\" tg-width=\"996\" tg-height=\"568\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Slipped Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Slipped Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 15:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158877090","content_text":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.\nEUA for the vaccine in India was originally expected in October but will now be pushed back.\nThe delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.\n\nWhat happened\nShares of Novavax were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by The Economic Times that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).\nSo what\nSII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according toThe Economic Times article.\nThe problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.\nThis delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.\nNow what\nNovavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.\nNovavax fell over 2% in premarket trading.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835449547,"gmtCreate":1629734905889,"gmtModify":1676530116979,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835449547","repostId":"1189910879","repostType":4,"isVote":1,"tweetType":1,"viewCount":2253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892174124,"gmtCreate":1628646190368,"gmtModify":1676529807235,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"X, CLF, NUE, AA.. all the materials stock ready toboom on this deal","listText":"X, CLF, NUE, AA.. all the materials stock ready toboom on this deal","text":"X, CLF, NUE, AA.. all the materials stock ready toboom on this deal","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/892174124","repostId":"1185123318","repostType":4,"isVote":1,"tweetType":1,"viewCount":2831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898725902,"gmtCreate":1628523372606,"gmtModify":1703507608186,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898725902","repostId":"2158442754","repostType":4,"isVote":1,"tweetType":1,"viewCount":2652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893382601,"gmtCreate":1628238268103,"gmtModify":1703503738908,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Submitted EUA in India, Indonesia and PhilippinesThose are the markets where vaccine are needed","listText":"Submitted EUA in India, Indonesia and PhilippinesThose are the markets where vaccine are needed","text":"Submitted EUA in India, Indonesia and PhilippinesThose are the markets where vaccine are needed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893382601","repostId":"1103242546","repostType":4,"isVote":1,"tweetType":1,"viewCount":3634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890001411,"gmtCreate":1628064152233,"gmtModify":1703500523823,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Pfizer slow and steady&nbsp;NVAX roller coaster rideChoose your poison&nbsp;","listText":"Pfizer slow and steady&nbsp;NVAX roller coaster rideChoose your poison&nbsp;","text":"Pfizer slow and steady NVAX roller coaster rideChoose your poison","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890001411","repostId":"1124757232","repostType":4,"isVote":1,"tweetType":1,"viewCount":2862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802787592,"gmtCreate":1627808771416,"gmtModify":1703496165724,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"ok well","listText":"ok well","text":"ok well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802787592","repostId":"2155001152","repostType":4,"isVote":1,"tweetType":1,"viewCount":3213,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806612256,"gmtCreate":1627653325275,"gmtModify":1703494180907,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Inflation rate keep climbing.. correction soon..&nbsp;","listText":"Inflation rate keep climbing.. correction soon..&nbsp;","text":"Inflation rate keep climbing.. correction soon..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806612256","repostId":"1109167679","repostType":4,"isVote":1,"tweetType":1,"viewCount":2786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801174817,"gmtCreate":1627493155939,"gmtModify":1703491117846,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Buy index and sleep well at night&nbsp;","listText":"Buy index and sleep well at night&nbsp;","text":"Buy index and sleep well at night","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/801174817","repostId":"2154918711","repostType":4,"isVote":1,"tweetType":1,"viewCount":3782,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3564210269929975","authorId":"3564210269929975","name":"kk__soh","avatar":"https://static.tigerbbs.com/f54f0205e29fd09d7864877ae54901e3","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3564210269929975","idStr":"3564210269929975"},"content":"Help me like if not I will go jail","text":"Help me like if not I will go jail","html":"Help me like if not I will go jail"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800665278,"gmtCreate":1627299121894,"gmtModify":1703487053811,"author":{"id":"3576835084140349","authorId":"3576835084140349","name":"ETCH","avatar":"https://static.tigerbbs.com/2f1ff4cf08fc7dbd87a3a3322be433e9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576835084140349","idStr":"3576835084140349"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800665278","repostId":"2154570979","repostType":2,"repost":{"id":"2154570979","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1627299058,"share":"https://ttm.financial/m/news/2154570979?lang=en_US&edition=fundamental","pubTime":"2021-07-26 19:30","market":"hk","language":"en","title":"Lockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2154570979","media":"Benzinga","summary":"Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same","content":"<html><body><p>Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same period last year.  The company reported quarterly sales of $16.26 billion which missed the analyst consensus estimate of $16.33 billion by 0.44 percent.  This is a 3.88 percent increase over sales of $15.65 billion the same period last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLockheed Martin Q1 EPS $6.56 Beats $6.30 Estimate, Sales $16.26B Miss $16.33B Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-26 19:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same period last year.  The company reported quarterly sales of $16.26 billion which missed the analyst consensus estimate of $16.33 billion by 0.44 percent.  This is a 3.88 percent increase over sales of $15.65 billion the same period last year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMT":"洛克希德马丁"},"source_url":"https://www.benzinga.com/news/earnings/21/07/22144945/lockheed-martin-q1-eps-6-56-beats-6-30-estimate-sales-16-26b-miss-16-33b-estimate","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154570979","content_text":"Lockheed Martin (NYSE:LMT) reported quarterly earnings of $6.56 per share which beat the analyst consensus estimate of $6.30 by 4.13 percent. This is a 7.89 percent increase over earnings of $6.08 per share from the same period last year.  The company reported quarterly sales of $16.26 billion which missed the analyst consensus estimate of $16.33 billion by 0.44 percent.  This is a 3.88 percent increase over sales of $15.65 billion the same period last year.","news_type":1,"symbols_score_info":{"LMT":1}},"isVote":1,"tweetType":1,"viewCount":2530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}